Ophthalmology · Anaheim, CA
NPI
1174500391
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 W Romneya Dr, Suite 403
Anaheim, CA, 92801
Phone (714) 491-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,010
46 services
Medicare patients, 2024
28
Average age 71
Drug cost, 2024
$132K
2,505 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Hyong S Choe prescribed most often to Medicare patients was Latanoprost, with 814 prescriptions and refills. In total Hyong S Choe wrote 2,505 Medicare prescriptions that cost $132K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Latanoprost Generic | 814 | 1,602 | 251 | $9,225 |
| Prednisolone Acetate Generic | 472 | 525 | 265 | $16K |
| Cyclosporine Generic | 300 | 494 | 107 | $45K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 268 | 878 | 116 | $7,308 |
| Brimonidine Tartrate Generic | 170 | 524 | 78 | $2,811 |
| Timolol Maleate Generic | 155 | 486 | 62 | $3,176 |
| Ketorolac Tromethamine Generic | 64 | 74 | 36 | $967 |
| Erythromycin Erythromycin Base | 36 | 36 | 31 | $520 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 26 | 26 | 22 | $373 |
| Travoprost Generic | 24 | 68 | Under 11 | $2,208 |
| Rhopressa Netarsudil Mesylate | 20 | 43 | Under 11 | $14K |
| Dorzolamide Hcl Generic | 19 | 58 | Under 11 | $610 |
| Nevanac Nepafenac | 18 | 21 | Under 11 | $11K |
| Pilocarpine Hcl Generic | 16 | 50 | Under 11 | $617 |
| Bimatoprost Generic | 14 | 29 | Under 11 | $1,199 |
Brand drugs: 845 claims; generic drugs: 1,660 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Hyong S Choe were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.